Trade Covetrus - CVET CFD
Market information is presented
as of 2023-09-21
- Summary
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Covetrus Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 20.65 |
Open* | 20.65 |
1-Year Change* | -0.1% |
Day's Range* | 20.64 - 20.67 |
52 wk Range | 13.39-21.20 |
Average Volume (10 days) | 2.17M |
Average Volume (3 months) | 26.09M |
Market Cap | 2.94B |
P/E Ratio | -100.00K |
Shares Outstanding | 139.97M |
Revenue | 4.65B |
EPS | -0.09 |
Dividend (Yield %) | N/A |
Beta | 1.50 |
Next Earnings Date | Nov 2, 2022 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 20.67 | 0.05 | 0.24% | 20.62 | 20.68 | 20.62 |
Jun 28, 2022 | 20.65 | -0.05 | -0.24% | 20.70 | 20.73 | 20.61 |
Jun 27, 2022 | 20.70 | 0.06 | 0.29% | 20.64 | 20.73 | 20.64 |
Jun 24, 2022 | 20.68 | -0.02 | -0.10% | 20.70 | 20.75 | 20.67 |
Jun 23, 2022 | 20.67 | 0.07 | 0.34% | 20.60 | 20.74 | 20.58 |
Jun 22, 2022 | 20.59 | 0.16 | 0.78% | 20.43 | 20.65 | 20.43 |
Jun 21, 2022 | 20.61 | 0.04 | 0.19% | 20.57 | 20.61 | 20.52 |
Jun 17, 2022 | 20.56 | 0.07 | 0.34% | 20.49 | 20.56 | 20.47 |
Jun 16, 2022 | 20.48 | -0.02 | -0.10% | 20.50 | 20.58 | 20.45 |
Jun 15, 2022 | 20.52 | 0.02 | 0.10% | 20.50 | 20.57 | 20.45 |
Jun 14, 2022 | 20.46 | -0.01 | -0.05% | 20.47 | 20.62 | 20.39 |
Jun 13, 2022 | 20.60 | 0.23 | 1.13% | 20.37 | 20.65 | 20.37 |
Jun 10, 2022 | 20.66 | -0.02 | -0.10% | 20.68 | 20.69 | 20.62 |
Jun 9, 2022 | 20.70 | 0.02 | 0.10% | 20.68 | 20.70 | 20.65 |
Jun 8, 2022 | 20.69 | 0.10 | 0.49% | 20.59 | 20.73 | 20.59 |
Jun 7, 2022 | 20.72 | 0.10 | 0.48% | 20.62 | 20.72 | 20.62 |
Jun 6, 2022 | 20.64 | -0.06 | -0.29% | 20.70 | 20.70 | 20.62 |
Jun 3, 2022 | 20.66 | 0.10 | 0.49% | 20.56 | 20.69 | 20.56 |
Jun 2, 2022 | 20.64 | -0.02 | -0.10% | 20.66 | 20.69 | 20.61 |
Jun 1, 2022 | 20.64 | -0.10 | -0.48% | 20.74 | 20.76 | 20.61 |
Covetrus Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total revenue | 4575 | 4339 | 3976 | 3777.99 | 3579.79 |
Revenue | 4575 | 4339 | 3976 | 3777.99 | 3579.79 |
Cost of Revenue, Total | 3717 | 3541 | 3227 | 3093.88 | 2927.77 |
Gross Profit | 858 | 798 | 749 | 684.112 | 652.025 |
Total Operating Expense | 4598 | 4334 | 4973 | 3640.9 | 3444.47 |
Selling/General/Admin. Expenses, Total | 720 | 707 | 660 | 538.469 | 516.703 |
Unusual Expense (Income) | 0 | -74 | 938 | 8.545 | 0 |
Operating Income | -23 | 5 | -997 | 137.098 | 135.322 |
Interest Income (Expense), Net Non-Operating | -32 | -46 | -54 | 2.975 | 2.528 |
Other, Net | 1 | 17 | 22 | 3.104 | 0.919 |
Net Income Before Taxes | -54 | -24 | -1029 | 143.177 | 138.769 |
Net Income After Taxes | -54 | -17 | -983 | 110.515 | 111.104 |
Minority Interest | 0 | -2 | 3 | -6.521 | -27.69 |
Equity In Affiliates | 0 | 0 | 1.233 | 1.294 | |
Net Income Before Extra. Items | -54 | -19 | -980 | 105.227 | 84.708 |
Net Income | -54 | -19 | -980 | 100.861 | 64.354 |
Income Available to Common Excl. Extra. Items | -54 | -19 | -980 | 105.227 | 84.708 |
Income Available to Common Incl. Extra. Items | -54 | -19 | -980 | 100.861 | 64.354 |
Diluted Net Income | -54 | -19 | -980 | 100.861 | 64.354 |
Diluted Weighted Average Shares | 137 | 118 | 107 | 111.339 | 111.193 |
Diluted EPS Excluding Extraordinary Items | -0.39416 | -0.16102 | -9.15888 | 0.94511 | 0.76181 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Diluted Normalized EPS | -0.14599 | -0.25466 | -3.15701 | 1.00435 | 0.76181 |
Total Extraordinary Items | -4.366 | -20.354 | |||
Depreciation / Amortization | 161 | 160 | 148 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total revenue | 1148 | 1122 | 1162 | 1189 | 1102 |
Revenue | 1148 | 1122 | 1162 | 1189 | 1102 |
Cost of Revenue, Total | 923 | 910 | 946 | 969 | 892 |
Gross Profit | 225 | 212 | 216 | 220 | 210 |
Total Operating Expense | 1142 | 1129 | 1166 | 1198 | 1105 |
Selling/General/Admin. Expenses, Total | 191 | 189 | 188 | 196 | 179 |
Depreciation / Amortization | 28 | 30 | 32 | 33 | 34 |
Operating Income | 6 | -7 | -4 | -9 | -3 |
Interest Income (Expense), Net Non-Operating | -7 | -6 | -8 | -9 | -9 |
Other, Net | 2 | 3 | -2 | 0 | 0 |
Net Income Before Taxes | 1 | -10 | -14 | -18 | -12 |
Net Income After Taxes | -2 | -3 | -4 | -31 | -16 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Net Income Before Extra. Items | -2 | -3 | -4 | -31 | -16 |
Net Income | -2 | -3 | -4 | -31 | -16 |
Income Available to Common Excl. Extra. Items | -2 | -3 | -4 | -31 | -16 |
Income Available to Common Incl. Extra. Items | -2 | -3 | -4 | -31 | -16 |
Diluted Net Income | -2 | -3 | -4 | -31 | -16 |
Diluted Weighted Average Shares | 138 | 134 | 137 | 137 | 136 |
Diluted EPS Excluding Extraordinary Items | -0.01449 | -0.02239 | -0.0292 | -0.22628 | -0.11765 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Diluted Normalized EPS | -0.0192 | 0.11828 | -0.02445 | -0.22153 | -0.10331 |
Unusual Expense (Income) | 0 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Current Assets | 1351 | 1420 | 1340 | 1086.6 | 1076.93 |
Cash and Short Term Investments | 183 | 290 | 130 | 23.324 | 16.656 |
Cash & Equivalents | 183 | 290 | 130 | 23.324 | 16.656 |
Total Receivables, Net | 555 | 574 | 493 | 480.009 | 503.517 |
Accounts Receivable - Trade, Net | 480 | 507 | 426 | 430.783 | 427.866 |
Total Inventory | 583 | 530 | 636 | 564.163 | 534.664 |
Prepaid Expenses | 30 | 26 | 30 | 19.109 | 22.089 |
Total Assets | 3410 | 3496 | 3359 | 2233.08 | 2217.02 |
Property/Plant/Equipment, Total - Net | 281 | 233 | 177 | 68.549 | 64.554 |
Property/Plant/Equipment, Total - Gross | 416 | 339 | 261 | 142.057 | 128.16 |
Accumulated Depreciation, Total | -135 | -106 | -84 | -73.508 | -63.606 |
Goodwill, Net | 1247 | 1187 | 1154 | 749.762 | 759.768 |
Intangibles, Net | 439 | 555 | 643 | 208.213 | 252.927 |
Long Term Investments | 49 | 52 | 45 | 21.678 | 22.974 |
Other Long Term Assets, Total | 43 | 49 | 98.277 | 39.871 | |
Total Current Liabilities | 698 | 691 | 829 | 572.563 | 511.586 |
Accounts Payable | 442 | 411 | 520 | 441.453 | 375.782 |
Accrued Expenses | 151 | 183 | 63 | 36.948 | 33.382 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 32 | 1 | 62 | 0.675 | 3.204 |
Other Current Liabilities, Total | 73 | 96 | 184 | 93.487 | 99.218 |
Total Liabilities | 1899 | 1959 | 2106 | 739.467 | 959.781 |
Total Long Term Debt | 1014 | 1068 | 1125 | 23.529 | 23.529 |
Long Term Debt | 1014 | 1068 | 1125 | 23.529 | 23.529 |
Deferred Income Tax | 13 | 28 | 48 | 16.372 | 18.908 |
Minority Interest | 23 | 36 | 10 | 92.432 | 366.554 |
Other Liabilities, Total | 151 | 136 | 94 | 34.571 | 39.204 |
Total Equity | 1511 | 1537 | 1253 | 1493.62 | 1257.24 |
Retained Earnings (Accumulated Deficit) | -1081 | -1027 | -1001 | 1575.83 | 1299.23 |
Other Equity, Total | -79 | -66 | -86 | -82.214 | -41.988 |
Total Liabilities & Shareholders’ Equity | 3410 | 3496 | 3359 | 2233.08 | 2217.02 |
Total Common Shares Outstanding | 138.012 | 136.018 | 111.621 | 111.193 | 111.193 |
Other Current Assets, Total | 51 | ||||
Common Stock | 1 | 1 | 1 | ||
Additional Paid-In Capital | 2670 | 2629 | 2339 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Current Assets | 1417 | 1351 | 1351 | 1419 | 1422 |
Cash and Short Term Investments | 117 | 183 | 187 | 230 | 211 |
Cash & Equivalents | 117 | 183 | 187 | 230 | 211 |
Total Receivables, Net | 627 | 555 | 568 | 596 | 605 |
Accounts Receivable - Trade, Net | 538 | 480 | 491 | 517 | 518 |
Total Inventory | 630 | 583 | 552 | 557 | 555 |
Prepaid Expenses | 43 | 30 | 44 | 36 | 51 |
Total Assets | 3470 | 3410 | 3420 | 3414 | 3440 |
Property/Plant/Equipment, Total - Net | 285 | 281 | 247 | 229 | 229 |
Property/Plant/Equipment, Total - Gross | 289 | 279 | 252 | 242 | 230 |
Accumulated Depreciation, Total | -142 | -135 | -125 | -120 | -112 |
Goodwill, Net | 1267 | 1247 | 1247 | 1187 | 1187 |
Intangibles, Net | 414 | 439 | 479 | 484 | 516 |
Long Term Investments | 48 | 49 | 96 | 95 | 86 |
Total Current Liabilities | 762 | 698 | 714 | 709 | 682 |
Accounts Payable | 507 | 442 | 428 | 427 | 416 |
Accrued Expenses | 52 | 63 | 62 | 55 | 57 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 52 | 32 | 46 | 31 | 17 |
Other Current Liabilities, Total | 151 | 161 | 178 | 196 | 192 |
Total Liabilities | 1942 | 1899 | 1918 | 1912 | 1920 |
Total Long Term Debt | 995 | 1014 | 1027 | 1040 | 1054 |
Long Term Debt | 995 | 1014 | 1027 | 1040 | 1054 |
Deferred Income Tax | 12 | 13 | 18 | 16 | 23 |
Minority Interest | 22 | 23 | 23 | 23 | 36 |
Other Liabilities, Total | 151 | 151 | 136 | 124 | 125 |
Total Equity | 1528 | 1511 | 1502 | 1502 | 1520 |
Common Stock | 1 | 1 | 1 | 1 | 1 |
Additional Paid-In Capital | 2691 | 2670 | 2659 | 2641 | 2637 |
Retained Earnings (Accumulated Deficit) | -1083 | -1081 | -1078 | -1074 | -1043 |
Other Equity, Total | -81 | -79 | -80 | -66 | -75 |
Total Liabilities & Shareholders’ Equity | 3470 | 3410 | 3420 | 3414 | 3440 |
Total Common Shares Outstanding | 139.143 | 138.012 | 137.732 | 137.36 | 136.342 |
Other Long Term Assets, Total | 39 | 43 |
- Annual
- Quarterly
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net income/Starting Line | -54 | -17 | -1022 | 107.382 | 92.044 |
Cash From Operating Activities | 102 | 53 | 103 | 157.904 | 108.191 |
Cash From Operating Activities | 171 | 166 | 155 | 64.1 | 59.053 |
Deferred Taxes | -22 | -32 | -25 | -4.8 | 6.186 |
Non-Cash Items | 99 | 2 | 1000 | 6.609 | 6.953 |
Cash Taxes Paid | 27 | 24 | 18 | 11.767 | 7.698 |
Changes in Working Capital | -92 | -66 | -5 | -15.387 | -56.045 |
Cash From Investing Activities | -140 | -5 | -65 | -29.368 | -128.526 |
Capital Expenditures | -60 | -58 | -39 | -22.025 | -20.665 |
Other Investing Cash Flow Items, Total | -80 | 53 | -26 | -7.343 | -107.861 |
Cash From Financing Activities | -66 | 104 | 66 | -119.695 | 15.036 |
Financing Cash Flow Items | -36 | -28 | 58 | -117.591 | 15.35 |
Issuance (Retirement) of Debt, Net | -30 | -122 | 1177 | -2.104 | -0.314 |
Foreign Exchange Effects | -3 | 8 | 3 | -2.173 | 2.241 |
Net Change in Cash | -107 | 160 | 107 | 6.668 | -3.058 |
Cash Interest Paid | 22 | 40 | 47 | ||
Total Cash Dividends Paid | 0 | -6 | -1174 | ||
Issuance (Retirement) of Stock, Net | 0 | 260 | 5 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -2 | -54 | -51 | -47 | -16 |
Cash From Operating Activities | -33 | 102 | 58 | -1 | -59 |
Cash From Operating Activities | 40 | 171 | 128 | 86 | 43 |
Deferred Taxes | 1 | -22 | -16 | -11 | -3 |
Non-Cash Items | 22 | 99 | 68 | 45 | 18 |
Changes in Working Capital | -94 | -92 | -71 | -74 | -101 |
Cash From Investing Activities | -29 | -140 | -119 | -24 | -13 |
Capital Expenditures | -11 | -60 | -38 | -24 | -13 |
Other Investing Cash Flow Items, Total | -18 | -80 | -81 | 0 | 0 |
Cash From Financing Activities | -5 | -66 | -37 | -34 | -3 |
Financing Cash Flow Items | -5 | -36 | -37 | -14 | -3 |
Issuance (Retirement) of Debt, Net | 0 | -30 | 0 | 0 | 0 |
Foreign Exchange Effects | 1 | -3 | -5 | -1 | -4 |
Net Change in Cash | -66 | -107 | -103 | -60 | -79 |
Total Cash Dividends Paid | 0 | 0 | 0 | ||
Issuance (Retirement) of Stock, Net | 0 | 0 | -20 |
Covetrus Company profile
About Covetrus Inc
Covetrus, Inc. is an animal-health technology and services company. The Company operates through three segments: North America, Europe, and Asia Pacific (APAC) & Emerging Markets. The Company's products and services include supply chain services, software services, and prescription management. The supply chain services offers a portfolio of products and services and value-added solutions for enhancing operating efficient practices and delivering animal care. Software services develops, provides, and supports veterinary practices with a range of veterinary software systems. This includes practice management software, data-driven applications, client communications tools, and related services. The prescription management platform, which integrates into veterinary practice management software and workflow, client engagement and outreach communications, and integrated veterinary-pharmacy services and is designed to improve medical compliance.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Covetrus Inc revenues increased 5% to $4.58B. Net loss increased from $19M to $54M. Revenues reflect North America segment increase of 14% to $2.72B, APAC & Emerging Markets segment increase of 15% to $461M. Higher net loss reflects Selling, general and administrative increase of 2% to $720M (expense), Depreciation in SGA increase of 7% to $32M (expense).
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
7 Custom House St
PORTLAND
MAINE 04101-4185
US
News

EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com